Health
Ozempic and Vision: What to Know
Health Points
- Lawsuits allege Novo Nordisk failed to warn about NAION linked to semaglutide.
- Drug labels note possible vision changes while manufacturers and regulators continue safety reviews.
- Most published data focus on semaglutide; studies report associations but not proven causation.
Researchers have observed mixed findings across studies, so experts emphasize that links do not establish a direct cause-and-effect relationship.
Clinicians note uncertainty about whether reported eye events stem from the medication itself or from rapid blood-sugar changes after treatment begins, and data for people using these drugs only for weight loss remain sparse.
“Look, the substantial majority of patients who take these drugs won’t ever have vision problems,”
Dr. Sunir Garg, retina specialist and American Academy of Ophthalmology spokesperson.
If you are taking a GLP-1 medication and have new or worsening vision changes, contact your clinician promptly to discuss evaluation and next steps.
